18% Higher From Here? This Analyst Sees More Upside For Beauty Stock That Has Outperformed The Market In 2022
Ulta Beatuy Inc (NASDAQ: ULTA) gave shareholders a reason to cheer this quarter.
As European Energy Bills Soar, Demand Is Rising In This Sector: 6 Stock Ideas
Inflation jumped to a new all-time high of 8.9% in July, sparking a cost-of-living crisis in Europe for the 19 countries bound by the euro, fueled by rising energy costs.
Elon Musk: Henry Ford Did It, You Can Too, Hemp’s Myriad Uses Including Cars, Fuel, Textiles & Beer!
As so often reported, hemp-based CBD has numerous uses in the development of medicines for a variety of conditions and illnesses.
But with Labor Day upon us, how about we look at some of the practical uses of hemp?
How About Receiving Monthly Dividend Payments? 2 REITs And 1 Energy Company To Consider
As high returns are harder to come by today than in the past two years, investing in dividend stocks that pay distributions monthly is a big advantage, as most firms tend to pay dividends quarterly.
These 3 S&P 500 Dividend Stocks Have High Compound Annual Growth Rates Through 2024
Based on consensus estimates among surveyed analysts, FactSet has determined which stocks in the S&P 500 that have the highest expected two-year dividend compound annual growth rate.
Cramer Chats With Signet Jewelers About $360M Blue Nile Deal, Expanding Market Share
Signet Jewelers Ltd. (NYSE: SIG) CEO Gina Drosos recently appeared on Jim Cramer’s ‘Mad Money’ to discuss the company's recent $360-million acquisition of online jewelry retailer Blue Nile.
These Stocks Take A Hit As Covid-19 Outbreak Leads To Megacity Lockdown In China
China announced on Thursday that it would declare a state of emergency in Chengdu, a prominent southwestern province.
Two High-Yielding Stocks Famed Gold And Subprime Mortgage Trader John Paulson Owns
John Paulson is a billionaire investor and hedge fund manager of Paulson & Co., which he founded in 1994 as an investment firm in New York. In the second quarter of 2022, Paulson & Co’s holdings decreased to 32 from 40 in the second quarter of 2021.
Psychedelics Funding At Its Best: $1.5M Destined To Psilocin Clinical Trials In Australia
Psychedelics biopharma company Lobe Sciences Ltd.
Nasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For Epilepsy
Biopharma company developing next-generation mental health treatments Bright Minds Biosciences Inc. (NASDAQ: DRUG) has closed its overnight offering for gross proceeds of approximately $4 million.